Water → 6-Methyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine

HRID 422094

Reaktionsgleichung

Reaktionsgleichung von HRID 422094
Br[CH2:2][C:3]([C:5]1[CH:10]=[CH:9][C:8]([CH3:11])=[CH:7][CH:6]=1)=O.[CH3:12][C:13]1[CH:14]=[CH:15][C:16]([NH2:19])=[N:17][CH:18]=1.C([O-])(O)=O.[Na+].O>CN(C)C=O>[CH3:12][C:13]1[CH:14]=[CH:15][C:16]2[N:17]([CH:2]=[C:3]([C:5]3[CH:10]=[CH:9][C:8]([CH3:11])=[CH:7][CH:6]=3)[N:19]=2)[CH:18]=1

Komponenten

6

Versuchsvorschrift

A solution of 2-bromo-1-p-tolyl-ethanone (500 mg, 2.3 mmol) in dimethylformamide (2 mL) was added slowly to a solution of 5-methyl-pyridin-2-yl-amine (249 mg, 2.3 mmol) in dimethylformamide (2 mL). NaHCO3 (386 mg, 4.6 mmol) was added in portions and the mixture was stirred at room temperature for 15 minutes, then at reflux for 1.5 hours. The mixture was cooled and poured into water (5 mL). The solid was collected, washed with water (2 mL) and recrystallized from dimethylformamide (5 mL) to yield the desired product 6-methyl-2-p-tolyl-imidazo[1,2-a]pyridine (360 mg, 70%). 1H NMR (300 MHz, DMSO-d6) δ 2.27 (s, 3H), 2.32 (s, 3H), 7.08 (d, 1H), 7.21 (d, 2H), 7.46 (d, 1H), 7.83 (d, 2H), 8.24 (s, 1H), 8.29 (s, 1H); ESI-MS (MK), 223.

Aufarbeitung

  1. temperatureat reflux for 1.5 hours
  2. temperatureThe mixture was cooled
  3. customThe solid was collected
  4. washwashed with water (2 mL)
  5. customrecrystallized from dimethylformamide (5 mL)

Quellen und Nachweise

ORD-Eintrag
ord-502d874d2fa440aca17a055d11e79049
Quelldatensatz
uspto-grants-2012_01
Patentnummer
US08101633B2

Verknüpfte Notizen

Wird geladen…